Recent literature has presented emerging roles for p38β in tumour progression including the ability to regulate TGF-1β and VEGF growth factor mediated survival of endothelial cells in the absence of the proapoptotic p38α [29]. This evidence concerns the gene MAPK11 and neoplasm.